Exploring receptor-ligand interactions, we observed that aDCs and CD8+T cells primarily collaborated in executing anti-tumor functions through APP|CD74 and COPA|CD74 receptor-ligand pairs (Fig. 7J). This evidence concerns the gene CD8A and neoplasm.